Ali Ayberk Besen

4PUBLICATIONS
8CO-AUTHORS
Tumour immunologyRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 08, 2024
Novel Index Combining Pan-Immune-Inflammatory Index and Hemoglobin Levels (PIV/Hb) Predicts Trismus Rates Efficiently after Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer.

Efsun Somay, Busra Yilmaz, Erkan Topkan

|Sep 27, 2024
Comment on: Does the Planning Target Volume Correlate with Toxicity for Head and Neck Cancer Patients Undergoing Radiation? A Prospective Observational Study.

Erkan Topkan, Efsun Somay, Ali Ayberk Besen

|Aug 18, 2020
Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy.

Erkan Topkan, Huseyin Mertsoylu, Ahmet Kucuk

|Jun 23, 2020
Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide.

Erkan Topkan, Ali A Besen, Huseyin Mertsoylu

Pageof 1

Frequent Collaborators

4 joint publications

Erkan Topkan

4 joint publications

Huseyin Mertsoylu

3 joint publications

Ugur Selek

2 joint publications

Ahmet Kucuk